pISSN 2636-0004eISSN 2636-0012
pISSN 2636-0004Demographic Characteristics of NVUGIB Patients
| Characteristic | Control ( |
Intervention ( |
Total ( |
|
|---|---|---|---|---|
| Age | 0.056 | |||
| Mean (SD) | 53.4 (14.3) | |||
| Median | 55.5 | |||
| <40 | 7 (21.9) | 6 (18.8) | 13 (20.3) | |
| 40–<60 | 9 (28.1) | 18 (56.3) | 27 (42.2) | |
| 60–<80 | 16 (50.0) | 8 (25.0) | 24 (37.5) | |
| Sex | 0.412 | |||
| Male | 21 (65.6) | 24 (75.0) | 45 (70.3) | |
| Female | 11 (34.4) | 8 (25.0) | 19 (29.7) | |
| Comorbidities† | 0.095 | |||
| No comorbidities | 3 (9.4) | 1 (3.1) | 4 (6.3) | |
| Minor | 23 (71.9) | 19 (59.4) | 42 (65.6) | |
| Major | 6 (18.8) | 12 (37.5) | 18 (28.1) | |
| Anticoagulant use | 0.516 | |||
| (–) | 30 (93.8) | 31 (96.9) | 61 (95.3) | |
| (+) | 2 (6.3) | 1 (3.1) | 3 (4.7) | |
| NSAID use | 0.033* | |||
| (–) | 28 (87.5) | 32 (100.0) | 60 (93.8) | |
| (+) | 4 (12.5) | 0 (0.0) | 4 (6.2) | |
| Hemorrhagic shock | 0.076 | |||
| (–) | 22 (68.8) | 14 (43.8) | 36 (56.2) | |
| (+) | 10 (31.3) | 18 (56.3) | 28 (43.8) | |
| Hemoglobin pre-hemostasis | 0.633 | |||
| < 7 g/dL | 10 (31.3) | 9 (28.1) | 19 (29.7) | |
| ≥ 7 g/dL | 22 (68.8) | 23 (71.9) | 45 (70.3) | |
| Rockall score | 0.312 | |||
| 0 | 2 (6.3) | 1 (3.1) | 3 (4.7) | |
| 1 | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| 2 | 11 (34.4) | 9 (28.6) | 20 (31.3) | |
| 3 | 9 (28.1) | 5 (15.6) | 14 (21.9) | |
| 4 | 3 (9.4) | 6 (18.8) | 9 (14.1) | |
| 5 | 6 (18.8) | 10 (31.3) | 16 (25.0) | |
| 6 | 1 (3.1) | 1 (3.1) | 2 (3.1) |